Skip to main content
. 2024 May 28;13(5):2357–2371. doi: 10.21037/tcr-23-2067

Figure 9.

Figure 9

TIDE scores with survival prediction and drug sensitivity analysis. (A) TIDE scores for the different risk groups. (B-D) The drug sensitivities of WZ4003, dasatinib, and entinostat were observed. ***, P<0.001. TIDE, tumor immune dysfunction and exclusion.